文章摘要
基于新修订《药品管理法》背景下的药物临床试验标准操作规程探讨邹宇玲,王雅雯,郑丽娥,高泽诚*,范玉明*(中国食品药品检定研究院,北京100050)
Discussion on Standard Operating Procedures of Clinical Trials of Drugs According to the New Edition of Drug Administration LawZuo Yuling, Wang Yawen, Zheng Li’e, Gao Zecheng*, Fan Yuming* (National Institutes for Food and Drug Control, Beijing 100050, China)
投稿时间：2019-12-04  修订日期：2019-12-06
DOI：
中文关键词: 
英文关键词: drug clinical trials  standard operating procedure(SOP)  review  revise
基金项目:
作者单位邮编
邹宇玲* 中国食品药品检定研究院 100050
摘要点击次数: 285
全文下载次数: 0
中文摘要:
      新修订《中华人民共和国药品管理法》(以下简称《药品管理法》)提出了药物临床试验应该遵守由国务院药品监督管理部门会同国务院有关部门制定的药物临床试验质量管理规范；以保证药物临床试验的规范性、结果科学、可靠性、完整性及可信性,以及保证受试者的权益和安全性；为了遵守新法规要求,本文探讨了基于新版《药品管理法》背景下,如何制定药物临床试验标准操作规程(SOP)的方法、制定SOP的范围,如何管理SOP、如何培训和审查SOP 等,为制定新法规的实施细则提供参考。
英文摘要:
      The new edition of the Drug Administration Law of the People"s Republic of China (hereinafter referred to as the "Drug Administration Law") proposes that clinical trials of drugs should comply with the Good Clinical Practices (GCP) formulated by the drug regulatory department of the State Council in conjunction with relevant departments of the State Council so as to ensure the standardization, scientificity, reliability, integrity and credibility of clinical trials of drugs and to ensure the rights and safety of subjects. In order to comply with the requirements of the new law, authors of the paper discuss how to formulate standard operating procedure (SOP) for clinical trials of drugs, the scope of SOP, how to manage SOP, how to train and review SOP, etc. according to the new edition of the Drug Administration Law in order to provide references for developing rules of implementation for the new law.
View Fulltext   查看/发表评论  下载PDF阅读器
关闭